New CFO at Vitrolife

New CFO at Vitrolife

Eva Nilsagård has been appointed as the new Head of Vitrolife's Accounting and
Finance department and Investor Relations.

Eva is presently Head of Business Support for Region Europe, including Business
Control, IT/IS, Quality and Environmental issues at Volvo Penta AB, a supplier
of power systems for marine and industrial applications. Previous to that Eva
held the position as Group Controller at Astra Tech AB, a med-tech company
wholly owned by AstraZeneca.

Eva will start at Vitrolife during the month of March.



December 19, 2008
Gothenburg, Sweden 

Magnus Nilsson
CEO





Queries should be addressed to: 
Magnus Nilsson, CEO, phone +46 31 721 80 00 or +46 708 22 80 61.
Anna Ahlberg, CFO, phone +46 31 721 80 13 or +46 708 22 80 13.


________________________________________________________________________________
_________
Vitrolife is a global biotechnology/medical device Group that works with
developing, manufacturing and selling advanced products and systems for the
preparation, cultivation and storage of human cells, tissue and organs. The
company has business activities within three product areas: Fertility,
Transplantation and Stem Cell Cultivation. The Fertility product area works with
nutrient solutions (media) and advanced consumable instruments such as needles
and pipettes, for the treatment of human infertility. The Transplantation
product area works with solutions and systems to maintain tissue in optimal
condition outside the body for the required time while waiting for
transplantation. The Stem Cell Cultivation product area works with media and
instruments to enable the use and handling of stem cells for therapeutic
purposes. 
     Vitrolife today has approximately 140 employees and the company's products
are sold in more than 80 markets. The head office is in Gothenburg, Sweden, and
there are subsidiaries in USA, Australia and Italy. The Vitrolife share is
listed on the OMX Nordic Exchange Stockholm's Nordic Small Cap list.
________________________________________________________________________________
_________
Vitrolife AB (publ), Box 9080, SE-400 92 Göteborg, Sweden. Corporate identity
number 556354-3452.
Tel: +46 31 721 80 00. Fax: +46 31 721 80 90. E-mail: info@vitrolife.com.
Homepage: www.vitrolife.com.

The information in this press release is such as that which Vitrolife is
required to publish in accordance with the Securities Exchange and Clearing
Operations Act. The information was submitted for publication on December 19,
2008 at 12.00.

This is a translation of the Swedish version of the interim report. When in
doubt, the Swedish wording prevails.